<ul>
<li>2026 年大麻黑马：税制改革如何重置股票估值</li>
</ul>
<p>根据 MarketBeat 的股票筛选工具，Tilray Brands、Canopy Growth 和 Flora Growth 是今天值得关注的三只大麻股票。大麻股票是指那些主要业务涉及大麻行业的上市公司股票——例如种植者、加工商、零售商、与大麻素合作的制药开发者或辅助服务提供商（设备、测试、分销和技术）。投资者将其视为消费/健康或新兴市场股票的一个子类别，虽然它们可能提供更高的增长潜力，但由于各地区法律的不同，也面临着更高的法律、监管和市场波动风险。这些公司在过去几天内的大麻股票交易量最高。</p>
<p>获取 <strong>Tilray Brands</strong> 警报：</p>
<h2>Tilray Brands (TLRY)</h2>
<p>Tilray, Inc. 从事医疗大麻的研究、种植、加工和分销。该公司在阿根廷、澳大利亚、加拿大、智利、克罗地亚、塞浦路斯、捷克共和国、德国、新西兰和南非提供其产品。Tilray, Inc. 总部位于加拿大。</p>
<ul>
<li>MarketBeat 周回顾 – 09/29 - 10/03</li>
</ul>
<p>阅读我们关于 TLRY 的最新研究报告</p>
<h2>Canopy Growth (CGC)</h2>
<p>Canopy Growth Corporation 及其子公司从事大麻和大麻基产品的生产、分销和销售，主要用于娱乐和医疗目的，业务遍及美国、加拿大、德国及国际市场。它通过加拿大大麻、国际市场大麻和 Storz &amp; Bickel 三个部门运营。</p>
<ul>
<li>Tilray 的股价飙升是政治炒作的幻想吗？</li>
</ul>
<p>阅读我们关于 CGC 的最新研究报告</p>
<h2>Flora Growth (FLGC)</h2>
<p>Flora Growth Corp.及其子公司从事全球范围内的医疗大麻及其衍生产品的种植、培育和开发。它通过三个部门运营：品牌之家、商业与批发以及制药。该公司种植、加工并供应医疗级大麻花及大麻衍生的医疗和健康产品。</p>
<p>阅读我们关于 FLGC 的最新研究报告</p>
<h2>了解更多</h2>
<ul>
<li>MarketBeat 2026 年 2 月值得拥有的五大股票</li>
<li>高通的分析师们放弃了——是时候勇敢了吗？</li>
<li>3 只折扣零售股票值得关注，因为财报考验估值</li>
<li>CRWD 股票：买入抄底还是小心估值？</li>
<li>3 只被忽视的股息股票适合 2026 年的动荡市场</li>
<li>SentinelOne 的抛售是警告信号还是机会？</li>
</ul>
<p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 到 Tilray Brands 吗？</h2>
<p>在考虑 Tilray Brands 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Tilray Brands 并不在名单上。</p>
<p>虽然 Tilray Brands 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

FLGC

TLRY

<p>根据 MarketBeat 的报道，Tilray Brands、Canopy Growth 和 Flora Growth 被认为是值得研究的顶级大麻股票。这些公司涉及大麻行业的各个方面，包括种植和分销。最近它们的交易量很高，显示出投资者的兴趣。尽管它们具有增长潜力，但由于监管和市场波动，大麻股票仍然存在风险。分析师目前对 Tilray 的评级为持有，建议投资者考虑其他顶级分析师推荐的股票</p>

<ul>
<li>The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations</li>
</ul>
<div class="lb-trans"><ul>
<li>2026 年大麻黑马：税制改革如何重置股票估值</li>
</ul>
</div><p>Tilray Brands, Canopy Growth, and Flora Growth are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies whose primary business involves the cannabis industry—such as growers, processors, retailers, pharmaceutical developers working with cannabinoids, or ancillary service providers (equipment, testing, distribution, and technology). Investors treat them as a subcategory of consumer/health or emerging-market equities that can offer higher growth potential but also carry elevated legal, regulatory and market-volatility risks due to differing laws across jurisdictions. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.</p>
<div class="lb-trans"><p>根据 MarketBeat 的股票筛选工具，Tilray Brands、Canopy Growth 和 Flora Growth 是今天值得关注的三只大麻股票。大麻股票是指那些主要业务涉及大麻行业的上市公司股票——例如种植者、加工商、零售商、与大麻素合作的制药开发者或辅助服务提供商（设备、测试、分销和技术）。投资者将其视为消费/健康或新兴市场股票的一个子类别，虽然它们可能提供更高的增长潜力，但由于各地区法律的不同，也面临着更高的法律、监管和市场波动风险。这些公司在过去几天内的大麻股票交易量最高。</p>
</div><p>Get <strong>Tilray Brands</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Tilray Brands</strong> 警报：</p>
</div><h2>Tilray Brands (TLRY)</h2>
<div class="lb-trans"><h2>Tilray Brands (TLRY)</h2>
</div><p>Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.</p>
<div class="lb-trans"><p>Tilray, Inc. 从事医疗大麻的研究、种植、加工和分销。该公司在阿根廷、澳大利亚、加拿大、智利、克罗地亚、塞浦路斯、捷克共和国、德国、新西兰和南非提供其产品。Tilray, Inc. 总部位于加拿大。</p>
</div><ul>
<li>MarketBeat Week in Review – 09/29 - 10/03</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 09/29 - 10/03</li>
</ul>
</div><p>Read Our Latest Research Report on TLRY</p>
<div class="lb-trans"><p>阅读我们关于 TLRY 的最新研究报告</p>
</div><h2>Canopy Growth (CGC)</h2>
<div class="lb-trans"><h2>Canopy Growth (CGC)</h2>
</div><p>Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz &amp; Bickel segments.</p>
<div class="lb-trans"><p>Canopy Growth Corporation 及其子公司从事大麻和大麻基产品的生产、分销和销售，主要用于娱乐和医疗目的，业务遍及美国、加拿大、德国及国际市场。它通过加拿大大麻、国际市场大麻和 Storz &amp; Bickel 三个部门运营。</p>
</div><ul>
<li>Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?</li>
</ul>
<div class="lb-trans"><ul>
<li>Tilray 的股价飙升是政治炒作的幻想吗？</li>
</ul>
</div><p>Read Our Latest Research Report on CGC</p>
<div class="lb-trans"><p>阅读我们关于 CGC 的最新研究报告</p>
</div><h2>Flora Growth (FLGC)</h2>
<div class="lb-trans"><h2>Flora Growth (FLGC)</h2>
</div><p>Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.</p>
<div class="lb-trans"><p>Flora Growth Corp.及其子公司从事全球范围内的医疗大麻及其衍生产品的种植、培育和开发。它通过三个部门运营：品牌之家、商业与批发以及制药。该公司种植、加工并供应医疗级大麻花及大麻衍生的医疗和健康产品。</p>
</div><p>Read Our Latest Research Report on FLGC</p>
<div class="lb-trans"><p>阅读我们关于 FLGC 的最新研究报告</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in February 2026</li>
<li>Qualcomm’s Analysts Are Throwing in the Towel—Time to Be Brave?</li>
<li>3 Discount Retail Stocks to Watch as Earnings Put Valuations to the Test</li>
<li>CRWD Stock: Buy the Dip or Beware the Valuation?</li>
<li>3 Overlooked Dividend Stocks for Choppy Markets in 2026</li>
<li>Is SentinelOne's Sell-Off a Warning Sign or an Opportunity?</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 2026 年 2 月值得拥有的五大股票</li>
<li>高通的分析师们放弃了——是时候勇敢了吗？</li>
<li>3 只折扣零售股票值得关注，因为财报考验估值</li>
<li>CRWD 股票：买入抄底还是小心估值？</li>
<li>3 只被忽视的股息股票适合 2026 年的动荡市场</li>
<li>SentinelOne 的抛售是警告信号还是机会？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Tilray Brands Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 到 Tilray Brands 吗？</h2>
</div><p>Before you consider Tilray Brands, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Tilray Brands 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Tilray Brands 并不在名单上。</p>
</div><p>While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Tilray Brands 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

2 月 18 日值得研究的顶级大麻股票